NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
FT. MYERS, FL / ACCESSWIRE / July 18, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report its second quarter 2023 financial results on Tuesday, …
Weiterlesen »